Cargando…
Pharmacokinetics of Quinacrine Efflux from Mouse Brain via the P-glycoprotein Efflux Transporter
The lipophilic cationic compound quinacrine has been used as an antimalarial drug for over 75 years but its pharmacokinetic profile is limited. Here, we report on the pharmacokinetic properties of quinacrine in mice. Following an oral dose of 40 mg/kg/day for 30 days, quinacrine concentration in the...
Autores principales: | Ahn, Misol, Ghaemmaghami, Sina, Huang, Yong, Phuan, Puay-Wah, May, Barnaby C. H., Giles, Kurt, DeArmond, Stephen J., Prusiner, Stanley B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388068/ https://www.ncbi.nlm.nih.gov/pubmed/22768295 http://dx.doi.org/10.1371/journal.pone.0039112 |
Ejemplares similares
-
Continuous Quinacrine Treatment Results in the Formation of Drug-Resistant Prions
por: Ghaemmaghami, Sina, et al.
Publicado: (2009) -
Pharmacokinetics of quinacrine in the treatment of prion disease
por: Yung, Lotus, et al.
Publicado: (2004) -
P-glycoprotein efflux transporter: a key to pharmacokinetic modeling for methadone clearance in fetuses
por: Ho, Harvey, et al.
Publicado: (2023) -
Contribution of Uptake and Efflux Transporters to
Oral Pharmacokinetics of Furosemide
por: Chapa, Revathi, et al.
Publicado: (2020) -
Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice
por: Nazor Friberg, Karah, et al.
Publicado: (2012)